ArticleCancer medicine2023

Radiotranscriptomics identified new mRNAs and miRNA markers for distinguishing prostate cancer from benign prostatic hyperplasia.

Qian Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.